Écrit par Didier Poli | 24 Mai 2017

Dr Tedros Adhanom Ghebreyesus was nominated by the Government of Ethiopia, and will begin his five-year term on 1 July 2017.

GENEVA, Switzerland, May 23, 2017 - Today the Members States of the World Health Organization (WHO) elected Dr Tedros Adhanom Ghebreyesus as the new Director-General of WHO.

Dr Tedros Adhanom Ghebreyesus was nominated by the Government of Ethiopia, and will begin his...

Écrit par Lysogene | 24 Mai 2017

L'accord stratégique de fabrication porte sur le produit de thérapie génique de Lysogene qui utilise le vecteur AAVrh10

PARIS, France et CAMBRIDGE, Mass., USA - le 24 mai 2017 - Lysogene, (la « Société » FR0013233475 - LYS) société biopharmaceutique spécialisée dans la thérapie génique ciblant les maladies du système nerveux central (SNC), annonce aujourd'hui la signature...

Écrit par Okayama University | 23 Mai 2017

(Okayama, 22 May) Researchers at Okayama University describe in Scientifc Reports the effect of a particular type of monoclonal antibody on epilepsy in mice. Findings include the prevention of disrupted brain–blood barrier function, the inhibition of inflammations, and prolonged epilepsy seizure latency.

Epilepsy is a category of neurological disorders characterized by recurrent...

Écrit par WHO | 23 Mai 2017

Madame President, Excellencies, honourable ministers, ambassadors, distinguished delegates, friends and colleagues, ladies and gentlemen,

I thank Member States for the trust shown when you appointed me as your Director-General more than ten years ago. I promised to work tirelessly, and have done so, but never got tired of the job, in the best and worst of times.

When I took office, I...